Cochlear | COH - Ebit

Stock Price
197.00
Daily Change
4.00 2.07%
Monthly
-28.60%
Yearly
-25.80%
Q1 Forecast
194.59

Cochlear reported AUD275M in EBIT for its fiscal semester ending in December of 2024.





Ebit Change Date
Ansell USD 117.3M 39.1M Jun/2024
Avita Medical AUD -8.66M 1.61M Jun/2025
Cochlear AUD 275M 25.5M Dec/2024
CSL USD 2.75B 1.35B Dec/2024
Fisher Paykel Healthcare NZD 298.2M 2.8M Dec/2025
Healius AUD 23.7M 26M Dec/2024
Integral Diagnostics AUD 24.99M 5.08M Jun/2024
Mayne Pharma AUD -16.2M 13.2M Jun/2024
Mesoblast USD -42.11M 21.69M Jun/2025
Monash IVF AUD 24.11M 3.3M Dec/2024
Nanosonics AUD 8.7M 2.6M Dec/2024
Polynovo AUD 840K 147K Jun/2024
Ramsay Health Care AUD 500.1M 14.8M Dec/2024
Regis Healthcare AUD 44.36M 13.1M Dec/2024
ResMed USD 497.6M 35.25M Dec/2025
Sigma Healthcare AUD 809K 13.76M Dec/2024
Somnomed AUD -1.99M 83.11K Jun/2023
Sonic Healthcare AUD 423.94M 80.3M Dec/2024
Telix Pharmaceuticals AUD 8.04M 3.21M Dec/2025